3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
10
Breast Neoplasms
9
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Adenomatous Polyposis Coli
4
Sarcoma
3
Glioblastoma
3
Central Nervous System Neoplasms
3
Paranasal Sinus Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Stomatitis
1
Smoldering Multiple Myeloma
1
Smoking
1
Recurrence
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Precancerous Conditions
1
Interventions
Sorafenib
52
pembrolizumab
26
Nivolumab
20
Bevacizumab
19
Radiosurgery
17
Doxorubicin
12
atezolizumab
9
Erlotinib Hydrochloride
9
lenvatinib
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
durvalumab
6
Ramucirumab
6
Radiofrequency Ablation
6
Cisplatin
6
Sunitinib
5
tislelizumab
4
regorafenib
4
Oxaliplatin
4
Leucovorin
4
Ipilimumab
4
Fluorouracil
4
Everolimus
4
Capecitabine
4
nintedanib
3
fluoromisonidazole
3
carotuximab
3
bavituximab
3
Tomography, X-Ray Computed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Hepatocellular
×
Celecoxib
×
Clear all
No trials found.